122 related articles for article (PubMed ID: 17202115)
1. Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort.
Harlap S; Paltiel O; Friedlander Y; Calderon-Margalit R; Deutsch L; Kleinhaus KR; Manor O; Neugut AI; Opler M; Perrin MC; Terry MB; Tiram E; Yanetz R
J Natl Cancer Inst; 2007 Jan; 99(1):77-81. PubMed ID: 17202115
[TBL] [Abstract][Full Text] [Related]
2. Late fetal death in offspring and subsequent incidence of prostate cancer in fathers: the Jerusalem Perinatal Study cohort.
Harlap S; Friedlander Y; Barchana M; Calderon R; Deutsch L; Kleinhaus KR; Perrin MC; Tiram E; Yanetz R; Paltiel O
Prostate; 2007 Jun; 67(9):989-98. PubMed ID: 17440938
[TBL] [Abstract][Full Text] [Related]
3. Re: Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort.
James WH
J Natl Cancer Inst; 2007 Jun; 99(11):902; author reply 903-4. PubMed ID: 17551157
[No Abstract] [Full Text] [Related]
4. Re: Prostate cancer in fathers with fewer male offspring: the Jerusalem Perinatal Study cohort.
Bermejo JL; Sundquist J; Hemminki K
J Natl Cancer Inst; 2007 Jun; 99(11):901-2; author reply 903-4. PubMed ID: 17551156
[No Abstract] [Full Text] [Related]
5. Fatherhood status and prostate cancer risk.
Jørgensen KT; Pedersen BV; Johansen C; Frisch M
Cancer; 2008 Feb; 112(4):919-23. PubMed ID: 18181100
[TBL] [Abstract][Full Text] [Related]
6. Family history of breast cancer as a predictor for fatal prostate cancer.
Rodríguez C; Calle EE; Tatham LM; Wingo PA; Miracle-McMahill HL; Thun MJ; Heath CW
Epidemiology; 1998 Sep; 9(5):525-9. PubMed ID: 9730031
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
8. Socio-economic and lifestyle factors associated with the risk of prostate cancer.
Lund Nilsen TI; Johnsen R; Vatten LJ
Br J Cancer; 2000 Apr; 82(7):1358-63. PubMed ID: 10755415
[TBL] [Abstract][Full Text] [Related]
9. Statin drugs and risk of advanced prostate cancer.
Platz EA; Leitzmann MF; Visvanathan K; Rimm EB; Stampfer MJ; Willett WC; Giovannucci E
J Natl Cancer Inst; 2006 Dec; 98(24):1819-25. PubMed ID: 17179483
[TBL] [Abstract][Full Text] [Related]
10. Recreational physical activity and risk of prostate cancer in a large cohort of U.S. men.
Patel AV; Rodriguez C; Jacobs EJ; Solomon L; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):275-9. PubMed ID: 15668508
[TBL] [Abstract][Full Text] [Related]
11. Diabetes and risk of prostate cancer in a prospective cohort of US men.
Rodriguez C; Patel AV; Mondul AM; Jacobs EJ; Thun MJ; Calle EE
Am J Epidemiol; 2005 Jan; 161(2):147-52. PubMed ID: 15632264
[TBL] [Abstract][Full Text] [Related]
12. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
13. Birth characteristics and risk of prostate cancer: the contribution of genetic factors.
Cnattingius S; Lundberg F; Sandin S; Grönberg H; Iliadou A
Cancer Epidemiol Biomarkers Prev; 2009 Sep; 18(9):2422-6. PubMed ID: 19690187
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.
Nieder AM; Porter MP; Soloway MS
J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517
[TBL] [Abstract][Full Text] [Related]
15. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
16. Residential sunlight exposure is associated with a decreased risk of prostate cancer.
John EM; Dreon DM; Koo J; Schwartz GG
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):549-52. PubMed ID: 15225836
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
18. The risk of cancer following hospitalization for infection in infancy: a population-based cohort study.
Paltiel O; Laniado DE; Yanetz R; Deutsch L; Calderon-Margalit R; Harlap S; Friedlander Y
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1964-8. PubMed ID: 17035406
[TBL] [Abstract][Full Text] [Related]
19. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
Parsons JK; Carter HB; Platz EA; Wright EJ; Landis P; Metter EJ
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2257-60. PubMed ID: 16172240
[TBL] [Abstract][Full Text] [Related]
20. Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study.
Karppi J; Kurl S; Nurmi T; Rissanen TH; Pukkala E; Nyyssönen K
Ann Epidemiol; 2009 Jul; 19(7):512-8. PubMed ID: 19443241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
